Skip to main content

Orexigen Therapeutics, Inc. (NASDAQ:OREX) Investor Files Lawsuit Against Certain Directors

  • If you are a current long-term stockholder of shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 13, 2013 (Shareholders Foundation) - An investor who currently holds NASDAQ:OREX shares, filed a lawsuit against directors of Orexigen Therapeutics, Inc. (NASDAQ:OREX) over alleged breaches of fiduciary duties. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties by awarding themselves in excess of the 1.5million annual stock ...



You must register (for free) or login to view the entire case.